Nordson said worldwide sales for the three months ended July 31, 2024 were $661,604, up 2.0% from the comparable period. The company said the increase included a 3.8% contribution from an acquisition, while organic sales decreased 0.9%.

1. 01

   Nordson said worldwide sales for the three months ended July 31, 2024 were $661,604, up 2.0% from the comparable period. The company said the increase included a 3.8% contribution from an acquisition, while organic sales decreased 0.9%.

2. 02

   The company said operating profit for the 3-month period was $167,058 (operating margin of 25.3%, compared with 26.4% in the prior-year period). It said net income was $117,327, or $2.04 per diluted share, compared with $2.22. Interest expense was $18,803, compared with $12,089 a year earlier.

3. 03

   Nordson said sales for the 3-month period were $370,561 for Industrial Precision Solutions (up 9.6%), $166,737 for Medical and Fluid Solutions (down 2.4%), and $124,306 for Advanced Technology Solutions (down 10.9%).

4. 04

   The company said cash provided by operating activities for the 9 months ended July 31, 2024 was $459,812 (compared with $478,072 in the prior-year period). It said it had net repayments of long-term debt of $244,355 and dividend payments of $116,789.

Key figures

Quarter ended July 31, 2024

Revenue

$662M

Operating income

$167M

Net income

$117M

EPS

$2.04

Analysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.